Ascendant Biomedical
Analysis completed on 3/18/2026
The submission contains highly exaggerated and unsubstantiated claims ('most people have used my product', audience is 'everyone') while failing to provide concrete evidence of traction, user metrics, or specific technical architecture. The stated $2.5M 'all time marketcap' under monthly revenue is confusing and contradictory for a team of 30 claiming global saturation. Due to the extreme vagueness and lack of verifiability, all criteria received the minimum quality multiplier.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline